Strut Coverage After Paclitaxel-Eluting Stent implantation Compared with Bare Metal Stent Implantation in the Superficial Femoral Artery: Optical Frequency Domain Imaging Study

Strut Coverage After Paclitaxel-Eluting Stent implantation Compared with Bare Metal Stent Implantation in the Superficial Femoral Artery: Optical Frequency Domain Imaging Study - Strut Coverage After Paclitaxel-Eluting Stent implantation Compared with Bare Metal Stent Implantation in the Superficial Femoral Artery: Optical Frequency Domain Imaging Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012565

Enrollment

Registered

2014-02-01

Start date

2013-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Artery Disease (PAD)

Interventions

Bare-metal nitinol stent implantation for the superficial femoral artery lesion Paclitaxel-eluting nitinol stent implantation for the superficial femoral artery lesion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients planned endovascular therapy with self-expanding stent for the de novo superficial femoral artery lesions (less than 15cm) in Hyogo College of Medicine

Exclusion criteria

Exclusion criteria: 1)Lesions with previous stent implantation 2)Lesions with previous FP-bypass 3)Acute or subacute limb ischemia 4)Patients without tolerance for antiplatelet agents 5)Patients without written informed consent

Design outcomes

Primary

Measure	Time frame
The percentage of uncovered stent struts 6 months after stent implantation	—

Secondary

Measure	Time frame
Neointimal volume 6 months after stent implantation	—

Countries

Japan

Contacts

Public ContactKojiro Miki

Hyogo College of Medicine Cardiovascular Division

hpxkg043@ybb.ne.jp0798456553

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026